Immunological criteria for evaluating the effectiveness of chemo targeted therapy of patients with metastatic colorectal cancer
In the literature overviuw the contemporary facts about using immunological possibilities of the effective cytostatic ^emotarget therapy in antitumor treatment for metastatic colorectal cancer patients are shown. It was shown high clinical effective using the oncological markers from different variants of ^emotarget therapy of the metastatic colorectal cancer patients.